J. Goldman & CO LP Merrimack Pharmaceuticals Inc Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$3.19 - $5.73 $485,183 - $871,504
-152,095 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$2.95 - $4.15 $153,680 - $216,194
52,095 Added 52.1%
152,095 $587,000
Q2 2018

Aug 14, 2018
BUY
$3.86 - $7.61 $386,000 - $761,000
100,000 New
100,000 $491,000

Others Institutions Holding MACK

# of Institutions
1
Shares Held
77
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email